Evidence map›Paper›PMID 35631515›Full record

ArticlePharmaceutics2022

Therapeutic Effects of Synthetic Triblock Amphiphilic Short Antimicrobial Peptides on Human Lung Adenocarcinoma.

Danjing Yang, Liang Zhu, Xiangyu Lin, Jiaming Zhu, Yusheng Qian, Wenhui Liu, Jianjun Chen, Chuncai Zhou, Jing He

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Danjing YangDepartment of Pathology and Pathophysiology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Liang ZhuDepartment of Pathology and Pathophysiology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Xiangyu LinDepartment of Pathology and Pathophysiology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Jiaming ZhuDepartment of Pathology and Pathophysiology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Yusheng QianSchool of Materials Science and Engineering, Tongji University, Shanghai 201804, China.
Wenhui LiuDepartment of Pathology and Pathophysiology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Jianjun ChenDepartment of Pathology and Pathophysiology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Chuncai ZhouSchool of Materials Science and Engineering, Tongji University, Shanghai 201804, China.
Jing HeDepartment of Pathology and Pathophysiology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Tongji University · CNShanghai Skin Disease Hospital · CN

Funding

the Research Program of Science and Technology Commission of Shanghai Municipality; Science Project of Shanghai Municipal commission of Health and family planning; National Student Innovation Training Program; Shanghai Student Innovation Training Program; 20JC1412300; 202040027; 202110247136; S202110247140; 81870920.
6 · The paper itself

Abstract

Because of their unique properties, antimicrobial peptides (AMPs) represent a potential reservoir of novel anticancer therapeutic agents. However, only a few AMPs can kill tumors with high efficiency, and obtaining inexpensive anticancer AMPs with strong activity is still a challenge. In our previous work, a series of original short amphiphilic triblock AMP (K

Indexed as

antimicrobial peptideslung cancermembrane disruptionstructure–activity relationshiptumoricidal capacities

Identifiers

PMID35631515
PMCPMC9143638
OpenAlexW4224323871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.